United States Pharmaceuticals

NextCure Inc (NXTC)

Track

Track

NextCure Inc. recorded thirteen insider trading transactions over the past ninety days. ADAR1 Capital Management, LLC aggressively accumulated shares, totaling over 1.6 million dollars in purchases. Conversely, Simcere Zaiming, Inc. divested 30,000 shares in August. These activities occurred following the company's latest earnings report, which showed a 7.07% positive surprise in quarterly performance.
Ticker: NXTC Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for NextCure Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Sofinnova Venture Partners IX, L.P. Large shareholder
Transaction date
Purchase
Price
36.75
Quantity 150,000 +5.9%
Value US$5,512,500
CANAAN X L.P. Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 50,000 +2.3%
Value US$750,000
3.3
Xu Stella
Transaction date
Purchase
Price
15.00
Quantity 125,000 +12.8%
Value US$1,875,000
2.5
Khuong Chau Quang
Transaction date
Purchase
Price
15.00
Quantity 350,000 +14.8%
Value US$5,250,000
3.8
SHANNON TIMOTHY M Non-Executive Director
Transaction date
Purchase
Price
15.00
Quantity 50,000 +2.3%
Value US$750,000
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 350,000 +14.8%
Value US$5,250,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-27 2026-10-27 B Purchase
4.0
ADAR1 Capital Management, LLC
Large shareholder
45,970 -25.1%
195.50
US$222,510 		45,970 -25.1% 195.50 US$222,510
2026-10-27 2026-10-26 B Purchase
4.0
ADAR1 Capital Management, LLC
Large shareholder
2,755 -19.7%
25.35
US$225,583 		2,755 -19.7% 25.35 US$225,583
2026-10-27 2026-10-23 B Purchase
4.0
ADAR1 Capital Management, LLC
Large shareholder
48,946 +47.3%
171.44
US$3,293,857 		48,946 +47.3% 171.44 US$3,293,857
2026-08-12 2026-08-10 S Sale
Simcere Zaiming, Inc.
30,000 -8.9%
6.16
US$184,800 		30,000 -8.9% 6.16 US$184,800
2026-08-03 2026-07-31 B Purchase
4.0
ADAR1 Capital Management, LLC
Large shareholder
8,003 +1.1%
4.80
US$38,414 		8,003 +1.1% 4.80 US$38,414
2026-08-03 2026-07-31 B Purchase
4.0
ADAR1 Capital Management, LLC
Large shareholder
25,000 +3.6%
4.98
US$124,540 		25,000 +3.6% 4.98 US$124,540
2026-08-03 2026-07-31 B Purchase
4.0
ADAR1 Capital Management, LLC
Large shareholder
3,300 +0.5%
4.98
US$16,420 		3,300 +0.5% 4.98 US$16,420
2026-08-03 2026-07-30 B Purchase
4.0
ADAR1 Capital Management, LLC
Large shareholder
77,850 +12.8%
4.96
US$385,793 		77,850 +12.8% 4.96 US$385,793
2026-08-03 2026-07-30 B Purchase
4.0
ADAR1 Capital Management, LLC
Large shareholder
100,000 +19.7%
4.90
US$490,000 		100,000 +19.7% 4.90 US$490,000
2026-08-03 2026-07-30 B Purchase
4.0
ADAR1 Capital Management, LLC
Large shareholder
25,000 +5.2%
4.81
US$120,338 		25,000 +5.2% 4.81 US$120,338
2026-08-03 2026-07-30 B Purchase
4.0
ADAR1 Capital Management, LLC
Large shareholder
20,000 +4.3%
5.00
US$100,000 		20,000 +4.3% 5.00 US$100,000
2026-08-03 2026-07-30 B Purchase
4.0
ADAR1 Capital Management, LLC
Large shareholder
20,000 +4.5%
5.00
US$100,000 		20,000 +4.5% 5.00 US$100,000
2026-08-03 2026-07-30 B Purchase
4.0
ADAR1 Capital Management, LLC
Large shareholder
50,000 +12.7%
4.97
US$248,615 		50,000 +12.7% 4.97 US$248,615
2026-07-29 2026-07-29 B Purchase
4.0
ADAR1 Capital Management, LLC
Large shareholder
1,600 +0.4%
5.00
US$8,000 		1,600 +0.4% 5.00 US$8,000
2026-07-29 2026-07-29 B Purchase
4.0
ADAR1 Capital Management, LLC
Large shareholder
1,810 +0.5%
5.00
US$9,050 		1,810 +0.5% 5.00 US$9,050
2026-07-29 2026-07-28 B Purchase
4.0
ADAR1 Capital Management, LLC
Large shareholder
6,400 +1.7%
4.95
US$31,677 		6,400 +1.7% 4.95 US$31,677
2026-07-29 2026-07-27 B Purchase
4.0
ADAR1 Capital Management, LLC
Large shareholder
7,798 +2.1%
5.00
US$38,985 		7,798 +2.1% 5.00 US$38,985
2019-11-19 2019-11-15 B Purchase Sofinnova Venture Partners IX, L.P. Large shareholder
150,000 +5.9%
36.75
US$5,512,500 		150,000 +5.9% 36.75 US$5,512,500
2019-05-15 2019-05-13 B Purchase
3.6
Sofinnova Venture Partners IX, L.P.
Large shareholder
400,000 +18.9%
15.00
US$6,000,000 		400,000 +18.9% 15.00 US$6,000,000
2019-05-13 2019-05-13 B Purchase
CANAAN X L.P.
Large shareholder
50,000 +2.3%
15.00
US$750,000 		50,000 +2.3% 15.00 US$750,000
2019-05-13 2019-05-13 B Purchase
3.3
Xu Stella
125,000 +12.8%
15.00
US$1,875,000 		125,000 +12.8% 15.00 US$1,875,000
2019-05-13 2019-05-13 B Purchase
2.5
Khuong Chau Quang
350,000 +14.8%
15.00
US$5,250,000 		350,000 +14.8% 15.00 US$5,250,000
2019-05-13 2019-05-13 B Purchase
3.8
SHANNON TIMOTHY M
Non-Executive Director
50,000 +2.3%
15.00
US$750,000 		50,000 +2.3% 15.00 US$750,000
2019-05-13 2019-05-13 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
350,000 +14.8%
15.00
US$5,250,000 		350,000 +14.8% 15.00 US$5,250,000
Explore more

More insider trading research around NextCure Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America